Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

April 14, 2017

Rabkin v. LION BIOTECHNOLOGIES, INC. et al

Track this case

Case Number:

3:17-cv-02086

Court:

California Northern

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Susan Illston

Firms

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. April 18, 2019

    Atty Fees, Costs Approved in $3.3M Lion Biotech Deal

    A California federal judge approved $816,000 in attorney fees and expenses to lead counsel Kessler Topaz as part of a $3.25 million settlement Lion Biotechnologies Inc. will pay to resolve investors' claims the company secretly sponsored news stories to inflate its stock.

4 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login